{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T00:59:44Z","timestamp":1790729984449,"version":"4.1.0"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2025,9,10]],"date-time":"2025-09-10T00:00:00Z","timestamp":1757462400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,9,10]],"date-time":"2025-09-10T00:00:00Z","timestamp":1757462400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Endocrine"],"DOI":"10.1007\/s12020-025-04406-5","type":"journal-article","created":{"date-parts":[[2025,9,10]],"date-time":"2025-09-10T12:43:48Z","timestamp":1757508228000},"page":"473-477","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Estimated fracture risk in osteopenic patients with primary hyperparathyroidism"],"prefix":"10.1007","volume":"90","author":[{"given":"Elena","family":"Castellano","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Garelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Attanasio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Boriano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giorgio","family":"Borretta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,9,10]]},"reference":[{"issue":"11","key":"4406_CR1","doi-asserted-by":"publisher","first-page":"2315","DOI":"10.1002\/JBMR.4665","volume":"37","author":"RV Minisola","year":"2022","unstructured":"R.V. Minisola, S. Arnold, A. Belaya, Z. Brandi, M.L. Clarke et al., Epidemiology, pathophysiology and genetics of primary hyperparathyroidism. J. Bone Min. Res. 37(11), 2315\u20132329 (2022). https:\/\/doi.org\/10.1002\/JBMR.4665","journal-title":"J. Bone Min. Res."},{"issue":"5","key":"4406_CR2","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1007\/s11154-024-09899-5","volume":"25","author":"A Palermo","year":"2024","unstructured":"A. Palermo, G. Tabacco, P. Makras, G. Zavatta, P. Trimboli et al., Primary hyperparathyroidism: from guidelines to outpatient clinic. Rev. Endocr. Metab. Disord. 25(5), 875\u2013896 (2024). https:\/\/doi.org\/10.1007\/s11154-024-09899-5","journal-title":"Rev. Endocr. Metab. Disord"},{"issue":"8","key":"4406_CR3","doi-asserted-by":"publisher","first-page":"991","DOI":"10.2174\/0118715303260423231122111705","volume":"24","author":"F Vescini","year":"2024","unstructured":"F. Vescini, G. Borretta, I. Chiodini, M. Boniardi, M. Carotti et al., Italian guidelines for the management of sporadic primary hyperparathyroidism. Endocr. Metab. Immune Disord Drug Targets. 24(8), 991\u20131006 (2024). https:\/\/doi.org\/10.2174\/0118715303260423231122111705","journal-title":"Endocr. Metab. Immune Disord Drug Targets"},{"key":"4406_CR4","doi-asserted-by":"publisher","unstructured":"J.P. Bilezikian, N.E. Cusano, A.A. Khan, J.M. Liu, C. Marcocci, Evaluation and management of primary hyperparathyroidism: summary statement and guidelines from the fifth international workshop. J Bone Miner Res. 2022;37(11):2293\u20132314. https:\/\/doi.org\/10.1002\/JBMR.4677","DOI":"10.1002\/JBMR.4677"},{"issue":"11","key":"4406_CR5","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.1007\/s40618-018-0879-z","volume":"41","author":"F Saponaro","year":"2018","unstructured":"F. Saponaro, F. Cetani, A. Repaci, U. Pagotto, C. Cipriani et al., Clinical presentation and management of patients with primary hyperparathyroidism in Italy. J. Endocrinol. Invest. 41(11), 1339\u20131348 (2018). https:\/\/doi.org\/10.1007\/s40618-018-0879-z","journal-title":"J. Endocrinol. Invest."},{"key":"4406_CR6","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1016\/j.jss.2024.01.013","volume":"296","author":"LN Krumeich","year":"2024","unstructured":"L.N. Krumeich, A. Santos, D.L. Fraker, R.R. Kelz, H. Wachtel, Modern trends for primary hyperparathyroidism: intervening on less biochemically severe disease. J. Surg. Res. 296, 489\u2013496 (2024). https:\/\/doi.org\/10.1016\/j.jss.2024.01.013","journal-title":"J. Surg. Res."},{"key":"4406_CR7","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1001\/jamainternmed.2021.7648","volume":"182","author":"CD Seib","year":"2022","unstructured":"C.D. Seib, T. Meng, I. Suh, J.E. Gosnell, W.T. Shen, Risk of fracture among older adults with primary hyperparathyroidism receiving parathyroidectomy vs nonoperative management. JAMA Intern. Med. 182, 10\u201318 (2022). https:\/\/doi.org\/10.1001\/jamainternmed.2021.7648","journal-title":"JAMA Intern. Med."},{"key":"4406_CR8","doi-asserted-by":"publisher","first-page":"875342","DOI":"10.3389\/fendo.2022.875342","volume":"13","author":"S Frey","year":"2022","unstructured":"S. Frey, M. G\u00e9rard, P. Guillot, M. Wargny, K. Bach-Ngohou et al., Parathyroidectomy improves bone density in women with primary hyperparathyroidism and preoperative osteopenia. Front. Endocrinol. (Lausanne). 13, 875342 (2022). https:\/\/doi.org\/10.3389\/fendo.2022.875342","journal-title":"Front. Endocrinol. (Lausanne)"},{"issue":"2","key":"4406_CR9","doi-asserted-by":"publisher","first-page":"bvae225","DOI":"10.1210\/jendso\/bvae225","volume":"9","author":"K Song","year":"2025","unstructured":"K. Song, R. Vijjhalwar, M. Aye et al., Assessing and managing primary hyperparathyroidism and fracture risk in england: survey of medical professionals. J. Endocr. Soc. 9(2), bvae225 (2025). https:\/\/doi.org\/10.1210\/jendso\/bvae225","journal-title":"J. Endocr. Soc."},{"issue":"9","key":"4406_CR10","doi-asserted-by":"publisher","first-page":"2023","DOI":"10.1007\/s00198-018-4560-1","volume":"29","author":"D Vodopivec","year":"2018","unstructured":"D. Vodopivec, P. Maslach, S. Markovic, T. Matic, Gender differences in bone mineral density in patients with primary hyperparathyroidism. Osteoporos. Int. 29(9), 2023\u20132030 (2018). https:\/\/doi.org\/10.1007\/s00198-018-4560-1","journal-title":"Osteoporos. Int."},{"issue":"6","key":"4406_CR11","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1007\/s00198-021-05822-9","volume":"32","author":"H Ejlsmark-Svensson","year":"2021","unstructured":"H. Ejlsmark-Svensson, L. Rolighed, T. Harsl\u00f8f, L. Rejnmark, Risk of fractures in primary hyperparathyroidism: a systematic review and meta-analysis. Osteoporos. Int. 32(6), 1053\u20131060 (2021). https:\/\/doi.org\/10.1007\/s00198-021-05822-9","journal-title":"Osteoporos. Int."},{"issue":"1","key":"4406_CR12","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.bone.2012.11.041","volume":"53","author":"E Romagnoli","year":"2013","unstructured":"E. Romagnoli, C. Cipriani, I. Nofroni, C. Castro, M. Angelozzi, A. Scarpiello, J. Pepe, D. Diacinti, S. Piemonte, V. Carnevale, S. Minisola, Trabecular bone score (TBS): an indirect measure of bone micro-architecture in postmenopausal patients with primary hyperparathyroidism. Bone. 53(1), 154\u2013159 (2013). Epub 2012 Dec 7. PMID: 23228370","journal-title":"Bone"},{"key":"4406_CR13","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1016\/j.jss.2025.01.003","volume":"306","author":"ZY Song","year":"2025","unstructured":"Z.Y. Song, S.J. Reddy, C. Wu et al., Changes in bone mineral density after parathyroidectomy in patients with primary hyperparathyroidism. J. Surg. Res. 306, 431\u2013436 (2025). https:\/\/doi.org\/10.1016\/j.jss.2025.01.003","journal-title":"J. Surg. Res."},{"key":"4406_CR14","unstructured":"J.A. Kanis, World Health Organization Scientific Group,. Assessment of osteoporosis at the primary healthcare level. WHO Technical Report. WHO Collaborating Centre, University of Sheffield, UK. 2008. Available from: http:\/\/www.shef.ac.uk\/FRAX\/index.htm"},{"issue":"5","key":"4406_CR15","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1007\/s40618-015-0261-3","volume":"38","author":"C Marcocci","year":"2015","unstructured":"C. Marcocci, M.L. Brandi, A. Scillitani, S. Corbetta, A. Faggiano et al., Italian society of endocrinology consensus statement: definition, evaluation and management of patients with mild primary hyperparathyroidism. J. Endocrinol. Invest. 38(5), 577\u2013593 (2015). https:\/\/doi.org\/10.1007\/s40618-015-0261-3","journal-title":"J. Endocrinol. Invest."},{"issue":"12","key":"4406_CR16","doi-asserted-by":"publisher","first-page":"2305","DOI":"10.1210\/js.2019-00316","volume":"3","author":"E Castellano","year":"2019","unstructured":"E. Castellano, R. Attanasio, A. Boriano, G. Borretta, Clinical presentation of primary hyperparathyroidism in older adults. J. Endocr. Soc. 3(12), 2305\u20132312 (2019). https:\/\/doi.org\/10.1210\/js.2019-00316","journal-title":"J. Endocr. Soc."},{"issue":"7","key":"4406_CR17","doi-asserted-by":"publisher","first-page":"2728","DOI":"10.1210\/jc.2016-1513","volume":"101","author":"E Castellano","year":"2016","unstructured":"E. Castellano, R. Attanasio, L. Gianotti, F. Cesario, F. Tassone et al., Forearm DXA increases the rate of patients with asymptomatic primary hyperparathyroidism meeting surgical criteria. J. Clin. Endocrinol. Metab. 101(7), 2728\u20132732 (2016). https:\/\/doi.org\/10.1210\/jc.2016-1513","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"4406_CR18","unstructured":"National Kidney Foundation. K\/DOQI clinical practice guidelines for chronic kidney disease: Evaluation, classification, and stratification. Am J Kidney Dis., 2002;39(2):S1-S266. PMID: 11904577"},{"issue":"1","key":"4406_CR19","doi-asserted-by":"publisher","first-page":"e0262572","DOI":"10.1371\/journal.pone.0262572","volume":"17","author":"A Rashid","year":"2022","unstructured":"A. Rashid, S. Chaudhary Hauge, C. Suetta, D. Hansen, Sarcopenia and risk of osteoporosis, falls and bone fractures in patients with chronic kidney disease: A systematic review. PLoS One. 17(1), e0262572 (2022). https:\/\/doi.org\/10.1371\/journal.pone.0262572","journal-title":"PLoS One"},{"issue":"4","key":"4406_CR20","doi-asserted-by":"publisher","first-page":"363","DOI":"10.24875\/GMM.24000107","volume":"160","author":"THA Tan","year":"2024","unstructured":"T.H.A. Tan, H. Johansson, N.C. Harvey, M. Lorentzon, J.A. Kanis et al., Assessment of fracture risk with FRAX and FRAXplus. Gac Med. Mex. 160(4), 363\u2013373 (2024). https:\/\/doi.org\/10.24875\/GMM.24000107","journal-title":"Gac Med. Mex"},{"issue":"3","key":"4406_CR21","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1007\/s00198-022-06629-y","volume":"34","author":"JA Kanis","year":"2023","unstructured":"J.A. Kanis, N.C. Harvey, E. Liu, L. Vandenput, M. Lorentzon, E.V. McCloskey, R. Bouillon, B. Abrahamsen, L. Rejnmark, H. Johansson, Danish Primary Hyperparathyroidism Study Group, Primary hyperparathyroidism and fracture probability. Osteoporos. Int. 34(3), 489\u2013499 (2023). https:\/\/doi.org\/10.1007\/s00198-022-06629-y","journal-title":"Osteoporos. Int."}],"container-title":["Endocrine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-025-04406-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12020-025-04406-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-025-04406-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T11:05:43Z","timestamp":1761735943000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12020-025-04406-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,10]]},"references-count":21,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2025,11]]}},"alternative-id":["4406"],"URL":"https:\/\/doi.org\/10.1007\/s12020-025-04406-5","relation":{},"ISSN":["1559-0100"],"issn-type":[{"value":"1559-0100","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,10]]},"assertion":[{"value":"19 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}